Risk Factors and Long-Term Prognosis for Chylothorax After Total Cavopulmonary Connection in Children: A

Liting Bai1, Zhengyi Feng1, Ju Zhao1

  • 1Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Frontiers in Pediatrics
|December 6, 2021
PubMed

Insights

Chylothorax after total cavopulmonary connection (TCPC) surgery occurs in 15.5% of children, leading to prolonged hospital stays and lower survival rates. A dominant right ventricle and high post-operative central venous pressure are key risk factors.

Area of Science:

  • Pediatric Cardiology
  • Thoracic Surgery
  • Critical Care Medicine

Background:

  • Chylothorax is a serious complication following total cavopulmonary connection (TCPC) in pediatric patients.
  • Understanding its incidence, risk factors, and prognosis is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the incidence and identify risk factors for chylothorax post-TCPC.
  • To assess the short- and long-term survival rates in children who develop chylothorax after TCPC.

Main Methods:

  • Retrospective review of 386 pediatric patients who underwent TCPC between 2008 and 2020.
  • Comparison of patients with and without post-operative chylothorax.
  • Univariate/multivariate analyses for risk factors and Kaplan-Meier for survival analysis.

Main Results:

  • Chylothorax incidence was 15.5% (60/386 patients).
  • Chylothorax patients experienced longer ICU and hospital stays, and more frequent adverse events like infection and pleural effusion.
  • Risk factors identified: dominant right ventricle (OR 2.711) and higher peak CVP on POD 0 (OR 1.116).

Conclusions:

  • The incidence of chylothorax after TCPC is lower than previously reported but significantly impacts survival.
  • Dominant right ventricle and elevated post-operative day 0 CVP are significant risk factors for chylothorax.
  • Improved management strategies are needed to mitigate the adverse effects of chylothorax on pediatric TCPC outcomes.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
444
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
588
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
613